1172MO Durvalumab consolidation in patients with stage III non-resecable NSCLC with driver genomic alterations

Autor: Melia, M. Riudavets, Auclin, E., Lamas, M.A. Mosteiro, Dempsey, N., Majem, M., Lobefaro, R., Castro, R. Lopez, Barrera, J. Bosch, Pilotto, S., Martín, E. Escalera, Tagliamento, M., Martinez, J. Mosquera, Zalcman, G., Nadal, E., Lopes, G., Signorelli, D., Campelo, M.R. Garcia, Besse, B., Planchard, D., Mezquita, L.
Zdroj: In Annals of Oncology September 2021 32 Supplement 5:S940-S941
Databáze: ScienceDirect